Details for 2018752026

Up to date per 26.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON CDKL5 STÖRUNGEN MIT DER VERBINDUNG OV329

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018752026

EP Publication Number

3579826

E-Number

1875212

Language

PCT Number

US18017382

Publication Date

18.12.2019 A

07.01.2026 B1

Registration Date

07.01.2026

AT Publication Date

15.01.2026

Application Date

08.02.2018

Registration Number

Priorities

08.02.2017

201762456320 P

IPC

A61K 31/196 20060101AFI20201009BHEP

Maximum Duration of Protection

08.02.2038

Owner

Ovid Therapeutics Inc.441 9th Avenue, 14th Floor New York, NY 10001US

Representative

Dipl.-Ing. Yorck Hernandezc/o Hernandez IP Ludwig-Ganghofer-Straße 4282031 GrünwaldDE

Inventor

DURING, Matthew14 Cedar Lane Weston, Connecticut 06883US

Information about Fees